INTERNATIONAL DIABETES SUMMIT 2020 VIDEOS
Two unusual and challenging diabetes cases By Dr Vijay Negalur

Two unusual and challenging diabetes cases By Dr Vijay Negalur
Case studies of diabetes management in frail, elderly people By Dr V Abichandani

Case studies of diabetes management in frail, elderly people By Dr V Abichandani
Case based perspectives in GDM: focus on diagnosis and therapy By Dr Rakesh Sahay

Case based perspectives in GDM: focus on diagnosis and therapy By Dr Rakesh Sahay
Corona Virus infection in people with diabetes and other comorbidities By Dr Bharat Purandre

Corona Virus infection in people with diabetes and other comorbidities By Dr Bharat Purandre
Cases of diabetic retinopathy: what should a physician know? By Dr SAVITA BHAT

Cases of diabetic retinopathy: what should a physician know? By Dr SAVITA BHAT
Case studies in diabetic nephropathy By Dr Manisha Sahay

Case studies in diabetic nephropathy By Dr Manisha Sahay
Anti-platelet therapy in diabetes: where are we now By Dr KAUSHIK RAY

Anti-platelet therapy in diabetes: where are we now By Dr KAUSHIK RAY
New understanding of type 2 diabetes, a reversible condition By Dr ROY TAYLOR

New understanding of type 2 diabetes, a reversible condition By Dr ROY TAYLOR
Achieving diabetes remission in the real world By Dr ROY TAYLOR

Achieving diabetes remission in the real world By Dr ROY TAYLOR
Vegan versus vegetarian diets: a critical look By Dr Neeta Deshpande

Vegan versus vegetarian diets: a critical look By Dr Neeta Deshpande
Ketodiet: a practical perspective + case studies By Dr Rucha Mehta

Ketodiet: a practical perspective + case studies By Dr Rucha Mehta
Demonstration of carbohydrate samples By Dr Vedavati Purandare

Demonstration of carbohydrate samples By Dr Vedavati Purandare
What is a "carb" and how is it counted? By Rutuja Mahajan

What is a "carb" and how is it counted? By Rutuja Mahajan
The renaissance of sulfonylurea therapy By Dr MATHEW JOHN

The renaissance of sulfonylurea therapy By Dr MATHEW JOHN
Glimepiride: the CAROLINA surprise By Dr KARTHIK BALACHANDRAN

Glimepiride: the CAROLINA surprise By Dr KARTHIK BALACHANDRAN
Metformin in GDM management By Dr ANITA NAMBIAR

Metformin in GDM management By Dr ANITA NAMBIAR
DPP4i in clinical practice: are there more differences than we thought? By Dr SAMIT GHOSAL

DPP4i in clinical practice: are there more differences than we thought? By Dr SAMIT GHOSAL
Vasculo metabolic effects with glucose lowering therapies, place of SGLT2i By Dr HEMRAJ CHANDALIA

Vasculo metabolic effects with glucose lowering therapies, place of SGLT2i By Dr HEMRAJ CHANDALIA
Evolving evidence with DPP4i: implications to practice By Dr ARPANDEV BHATTACHARYA

Evolving evidence with DPP4i: implications to practice By Dr ARPANDEV BHATTACHARYA
Glycaemia control and cardiovascular outcomes By Dr TINY NAIR

Glycaemia control and cardiovascular outcomes By Dr TINY NAIR
VERIFY: The India sub-analysis By Dr UDAY PHADKE

VERIFY: The India sub-analysis By Dr UDAY PHADKE
Translating ADVANCE trial benefits into clinical practice By Dr Murali K Ganguri

Translating ADVANCE trial benefits into clinical practice By Dr Murali K Ganguri
What's new about alogliptin - examining the EXAMINE trial By Dr Ameya Joshi

What's new about alogliptin - examining the EXAMINE trial By Dr Ameya Joshi
Using clinical trials to choose DPP4i therapy: focus on case studies By Dr MANOJ CHAWLA

Using clinical trials to choose DPP4i therapy: focus on case studies By Dr MANOJ CHAWLA
Psychosocial aspects of diabetes - a unique India perspectiveBy Dr ARCHANA SARDA

Psychosocial aspects of diabetes - a unique India perspectiveBy Dr ARCHANA SARDA
Glucose targets in non-critically ill subjects: case study By Dr ARUN MEMON

Glucose targets in non-critically ill subjects: case study By Dr ARUN MEMON
Glucose targets in critically ill: case based learning By Dr Sanjay Agarwal

Glucose targets in critically ill: case based learning By Dr Sanjay Agarwal
Glucose control in hospitalised people - introductory case By Dr.VEDANTI PURANDARE & ASHUTOSH PAKALE

Glucose control in hospitalised people - introductory case By Dr.VEDANTI PURANDARE & ASHUTOSH PAKALE
Glycemic management in diabetic foot with chronic kidney disease By Dr ANJALI BHATT

Glycemic management in diabetic foot with chronic kidney disease By Dr ANJALI BHATT
CGM for in-hospital care: an experimental tool By Dr RAJESH JAVHERANI

CGM for in-hospital care: an experimental tool By Dr RAJESH JAVHERANI
Complications screening program in a diabetes clinic By Dr A G Unnikrishnan

Complications screening program in a diabetes clinic By Dr A G Unnikrishnan
Running a successful diabetes clinic - what are the basics to know? By Dr K Srikanth

Running a successful diabetes clinic - what are the basics to know? By Dr K Srikanth
Incorporating innovations in day to day practice By Dr Sunil M Jain

Incorporating innovations in day to day practice By Dr Sunil M Jain
Introduction to Time-In-Range By Dr A G Unnikrishnan

Introduction to Time-In-Range By Dr A G Unnikrishnan
Time-In-Range vs HbA1c - Why TIR is a must in today's era? By Dr Banshi Saboo

Time-In-Range vs HbA1c - Why TIR is a must in today's era? By Dr Banshi Saboo
AGP & TIR correlation; managing T1 & T2 is now easy! - case presentation By Dr Kalyan Chakravarthy

AGP & TIR correlation; managing T1 & T2 is now easy! - case presentation By Dr Kalyan Chakravarthy
Applying new subclinical hypothyroidism guidelines: case Studies By Dr KARTHIK BALCHANDRAN

Applying new subclinical hypothyroidism guidelines: case Studies By Dr KARTHIK BALCHANDRAN
Challenges in the management of hypothyroidism By Dr Uday Phadke

Challenges in the management of hypothyroidism By Dr Uday Phadke
ITS FOGSI recommendations on thyroid disorders and pregnancy By Dr Altamash Shaikh

ITS FOGSI recommendations on thyroid disorders and pregnancy By Dr Altamash Shaikh
Anti-thyroid drugs how much and how long? By Dr Arpandev Bhattacharya

Anti-thyroid drugs how much and how long? By Dr Arpandev Bhattacharya
Choosing anti-diabetes agents for the best CV outcome By Dr BINAYAK SINHA

Choosing anti-diabetes agents for the best CV outcome By Dr BINAYAK SINHA
SGLT2i and renal outcomes in diabetes: what is new? By Dr K Srikanth

SGLT2i and renal outcomes in diabetes: what is new? By Dr K Srikanth
Heart failure in diabetes: what's new for the diabetologist? By Dr C K Pondey

Heart failure in diabetes: what's new for the diabetologist? By Dr C K Pondey
Kidney as a window to heart: further analysis from CREDENCE By Dr Awadhesh Kumar Sing

Kidney as a window to heart: further analysis from CREDENCE By Dr Awadhesh Kumar Sing
Emerging concepts in the management of hypertension in diabetes By Dr Tiny Nair

Emerging concepts in the management of hypertension in diabetes By Dr Tiny Nair
Standard of care in post ACS patient - A guideline based approach By Dr M S Hiremath

Standard of care in post ACS patient - A guideline based approach By Dr M S Hiremath
Treat to prevent CV renal disease progression in diabetes - a paradigm shift By Dr Mangesh Tiwaskar

Treat to prevent CV renal disease progression in diabetes - a paradigm shift By Dr Mangesh Tiwaskar
Lipids and CVD- the importance of treating to risk By Dr KAUSHIK RAY

Lipids and CVD- the importance of treating to risk By Dr KAUSHIK RAY
Heart failure and diabetes By Dr SHAILAJA KALE

Heart failure and diabetes By Dr SHAILAJA KALE
Medical management of heart failure By Dr SUNIL SATHE

Medical management of heart failure By Dr SUNIL SATHE
Diabetes & heart failure - a deadly combination By Dr Uday Phadke

Diabetes & heart failure - a deadly combination By Dr Uday Phadke
SGLT2i - efficacy and safety in clinical practice By Dr Shailaja Kale

SGLT2i - efficacy and safety in clinical practice By Dr Shailaja Kale
SGLT2i : from prevention to treatment By Dr Samit Ghosal

SGLT2i : from prevention to treatment By Dr Samit Ghosal
GLP 1 in cardiovascular diabetology By Dr BINAYAK SINHA

GLP 1 in cardiovascular diabetology By Dr BINAYAK SINHA
Addressing inertias to injections with once weekly options in type 2 diabetes By Dr Rajiv Kovil

Addressing inertias to injections with once weekly options in type 2 diabetes By Dr Rajiv Kovil
How to interpret autoantibody positivity?By Dr C B SANJEEVI

How to interpret autoantibody positivity?By Dr C B SANJEEVI
The case for pumps + CGMS in all type 1 diabetes By Dr Mohan Shenoy

The case for pumps + CGMS in all type 1 diabetes By Dr Mohan Shenoy
Type 1 diabetes may be managed with SMBG + MDI By Dr Ganesh Jevalikar

Type 1 diabetes may be managed with SMBG + MDI By Dr Ganesh Jevalikar
Non-insulin management of type 1 diabetes: what is the latest? By Dr ANANDA BASU

Non-insulin management of type 1 diabetes: what is the latest? By Dr ANANDA BASU
Popular Courses
Rated 5 out of 5 based on 5 customer ratings
₹2,900.00
Rated 5 out of 5 based on 5 customer ratings
₹7,000.00
Rated 5 out of 5 based on 5 customer ratings
₹4,900.00
Rated 5 out of 5 based on 5 customer ratings
₹2,900.00
Rated 5 out of 5 based on 5 customer ratings
₹1,950.00
Subscribe to receive our latest updates
- © 2024 Chellaram Diabetes Institute.All rights reserved.